Amgen Reports Third Party Data Breach Due to Incident at Sirva Relocation | Console and partner, PC

On September 24, 2024, Amgen, Inc. filed a notice of data breach with the Massachusetts Attorney General after it was discovered that confidential information provided to the company was compromised following an incident at Sirva Relocation, LLC (“Sirva”) were exposed to access. ). In this notice, Amgen explains that the incident resulted in an unauthorized party being able to access confidential information of certain individuals, including their names, social security numbers, financial account information, employment information, medical information, contact information and dates of birth. After completing the investigation, Amgen began sending data breach notification letters to all individuals whose data was affected by the recent data security incident.

If you have received a data breach notification from Amgen, it is important that you understand what is at risk and what you can do about it. A data breach attorney can help you learn more about how to protect yourself from becoming a victim of fraud or identity theft and discuss your legal options following the Amgen/Sirva data breach. For more information, see our recent article on this topic Here.

What caused the Amgen/Sirva data breach?

The Amgen/Sirva data breach was recently disclosed and more information is expected in the near future. However, Amgen's filing with the Massachusetts Attorney General provides some important information about what led to the breach. According to this source, Sirva became aware of suspicious activity on its computer network on September 29, 2023. In response, Sirva launched an investigation that ultimately confirmed that an unauthorized party was able to access parts of its IT network between August 16, 2023 and October 17, 2023. During this period, certain files containing confidential information provided to Sirva stored by Amgen were copied by the unauthorized actor.

After learning that sensitive consumer data was accessible to unauthorized parties, Sirva reviewed the compromised files to determine what information was leaked and which consumers were affected. On August 24, 2024, Sirva informed Amgen of the incident and that the leaked data included information that Amgen had provided to Sirva. While breached information varies from person to person, it may include your name, social security number, financial account information, employment information, medical information, contact information, and date of birth.

On September 24, 2024, Amgen sent data breach letters to everyone affected by the recent data security incident. These letters should provide victims with a list of information belonging to them that was compromised.

More information about Amgen

Amgen Inc. is a biotechnology company headquartered in Thousand Oaks, California. Amgen's best-selling products are Enbrel, used to treat rheumatoid arthritis and other autoimmune diseases, and Neulasta, used to prevent infections in patients undergoing cancer chemotherapy. Amgen employs more than 26,700 people and generates annual sales of around $29.5 billion.